Cresset Asset Management, LLC Standard Biotools Inc. Transaction History
Cresset Asset Management, LLC
- $17.6 Billion
- Q1 2025
A detailed history of Cresset Asset Management, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 24,902 shares of LAB stock, worth $32,621. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,902
Previous 28,871
13.75%
Holding current value
$32,621
Previous $50,000
48.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding LAB
# of Institutions
159Shares Held
279MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$99.7 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$76.8 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$22.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$14 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $103M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...